top of page

News

7th January 2021 - The CARBALIVE Consortium announces positive results of a Phase 2 equivalent trial of engineered macroporous carbons as a novel treatment for cirrhosis - read more

The CARBALIVE Consortium announces positive results of a Phase 2 equivalent trial of engineered macroporous carbons as a novel treatment for cirrhosis - CARBALIVE

Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure - YAQRIT

Phase 2 equivalent randomised, double-blind clinical trial of CarbaliveTM - Results Summary

Carbalive mentioned by EU Commissioner for Research, Science and Innovation at the First NASH-NAFLD Summit that took place on May 31. read more

Tiny Beads of hope for liver patients - Sunday Times - 13th November, 2016

The Sunday Times has published an article relating to the revolutionary development being undertaken within the CARBALIVE project.

CARBALIVE - Manufacturing a new drug video

bottom of page